MoneyWorks4Me

Windlas Biotech - Quaterly Results

01 Nov 2021 Evaluate
The September 2021 quarter revenue stood at Rs. 1152.52 millions, up 13.75% as compared to Rs. 1013.21 millions during the corresponding quarter last year.The Net proft of the company remain more or less same to Rs. 83.26  millions from Rs. 94.39 millions ,decline by -11.79%.Operating profit surged to 144.01 millions from the corresponding previous quarter of 129.56 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202109 202009 % Var
Sales 1152.52 1013.21 13.75 1152.52 1013.21 13.75 1152.52 1013.21 13.75
Other Income 12.19 6.22 95.98 12.19 6.22 95.98 12.19 6.22 95.98
PBIDT 144.01 129.56 11.15 144.01 129.56 11.15 144.01 129.56 11.15
Interest 4.36 3.03 43.89 4.36 3.03 43.89 4.36 3.03 43.89
PBDT 139.65 126.53 10.37 139.65 126.53 10.37 139.65 126.53 10.37
Depreciation 30.75 32.82 -6.31 30.75 32.82 -6.31 30.75 32.82 -6.31
PBT 108.90 93.71 16.21 108.90 93.71 16.21 108.90 93.71 16.21
TAX 25.64 -0.68 -3870.59 25.64 -0.68 -3870.59 25.64 -0.68 -3870.59
Deferred Tax -2.12 -0.68 211.76 -2.12 -0.68 211.76 -2.12 -0.68 211.76
PAT 83.26 94.39 -11.79 83.26 94.39 -11.79 83.26 94.39 -11.79
Equity 108.97 64.11 69.97 108.97 64.11 69.97 108.97 64.11 69.97
PBIDTM(%) 12.50 12.79 -2.28 12.50 12.79 -2.28 12.50 12.79 -2.28
Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..